Concepedia

Publication | Closed Access

Pharmacokinetics and toxicity of docetaxel: Role of CYP3A, MDR1, and GST polymorphisms

138

Citations

47

References

2006

Year

Abstract

Patients carrying the CYP3A*1B allele may have enhanced docetaxel clearance and may be underexposed, whereas those carrying GSTP1*A/*B and 3435TT genotypes may have excessive hematologic toxicity. Further studies are warranted to determine the usefulness of genotyping before docetaxel treatment.

References

YearCitations

2004

5.7K

2000

2.4K

2001

2.2K

1991

956

2001

749

1997

742

1997

721

1998

678

2002

661

2003

654

Page 1